Cardiovascular Associates of America Extends into Kissimmee with Cardiovascular Associates Marking 6th Alliance in Florida

Explosive Growth in Florida with Cardiovascular Associates Alliance Adds 35th Location

Today, Cardiovascular Associates of America (“CVAUSA”), a comprehensive cardiology practice management services organization, announced that Cardiovascular Associates (“CA”) has joined their elite physician alliance. CA is the leading cardiovascular practice in the greater Kissimmee region. Serving patients in Kissimmee, Orlando, Celebration, St. Cloud, Poinciana and Haines City/Davenport.

Cardiovascular Associates offers a comprehensive and compassionate approach to their patients by providing full-service care including cardiovascular medicine, interventional cardiology, invasive cardiology, electrophysiology and diagnostic testing and imaging.

“Cardiovascular Associates couldn’t be more excited to join CVAUSA, and partner our practice with an organization that prides itself on patient satisfaction and next-generation care delivery. Our practice has been servicing Central Florida residents for over 40 years,” said Patrick Mathias, MD, Cardiovascular Associates. “Together with CVAUSA we will excel to new levels and be able to provide our patients with the top level care they have come to expect throughout the organization and at our various locations. With this strategic alliance we will continue to deliver quality care and treatment to the families we serve while providing affordable cardiac care.”

CA has nine board certified physicians and four nurse practitioners with a staff of more than 65 team members who are top ranked, highly trained, and compassionate. Their goal is to collaborate every day to maintain and enhance the health and wellbeing of their patients. Through the alliance with CVAUSA CA will have the ability to expand services within their office at affordable prices like immediate same-day care.

“CVAUSA’s presence in Florida continues to expand with our first Orlando area partnership. I am delighted to work with the excellent physicians and staff at Cardiovascular Associates based in Kissimmee. This group has a longstanding A+ reputation in the Orlando region, and I know that firsthand since I reside in Orlando,” said Tim Attebery, CEO, CVAUSA. “CVAUSA looks forward to helping CA grow, open new offices, recruit new physicians, add new services, and offer innovative ways to better serve their patients while also lowering the total cost of cardiovascular care. I am very honored CA chose to partner with CVAUSA!”

Cardiovascular Associates of America has created a business model that enables cardiovascular specialists to retain physician autonomy and ownership augmented by sharing best practices, access to capital, and executive management support. Cardiology group practices within our network will continue to drive all clinical decisions, manage local operations, and be highly involved in strategic operations at the national level.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”